NYMC Faculty Publications
Delayed vs Early Cardioversion in Patients With Paroxysmal Atrial Fibrillation: A Population-Based Study (2015-2020)
Author Type(s)
Faculty
DOI
10.2217/fca-2023-0069
Journal Title
Future Cardiology
First Page
441
Last Page
452
Document Type
Article
Publication Date
7-1-2023
Department
Medicine
Abstract
There is limited data on clinical outcomes of delayed cardioversion (DCV) compared with early cardioversion (ECV) in paroxysmal atrial fibrillation (AF) patients. We utilized data from National Inpatient Sample (2015-2020) and propensity-score matched analysis to determine adjusted odds ratio (aOR) of major clinical outcomes, including 17,879 AF cases: 9725 and 8154 underwent ECV and DCV, respectively. Compared with ECV, DCV was associated with higher odds of acute heart failure (AHF; aOR 1.79 [1.67-1.92]; p < 0.01), median length of stay (4 vs 2 days; p < 0.01) and cost of hospitalization ($33,410 vs $21,738; p < 0.01) with no significant difference in inpatient mortality and other cardiovascular and neurological outcomes. Compared with ECV, DCV was associated with more AHF and resource utilization.
Recommended Citation
Mohamed, M. S., Hashem, A., Khalouf, A., Osama, M., Pendela, V. S., Rai, D., Aronow, W. S., & Balmer-Swain, M. (2023). Delayed vs Early Cardioversion in Patients With Paroxysmal Atrial Fibrillation: A Population-Based Study (2015-2020). Future Cardiology, 19 (9), 441-452. https://doi.org/10.2217/fca-2023-0069